Celera Diagnostics and Merck extend Alzheimer's collaboration
9th Sep 2005, 02:03 GMT
Celera Diagnostics has extended its collaboration with Merck & Co aimed at developing new treatments for Alzheimer's disease, the most common form of dementia among the elderly.
Latest news from Pharmaceutical Business Review Online:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol